Dr Wei Siang Yu, Chairman & Founder of Borderless Healthcare Group
Dr Wei went from a top medical student, graduating with MBBS (Hons) from Monash University in 1995, to become a medical inventor pioneering disruptive and transformative platforms around the world.
More than 20 years ago, Dr Wei invented the first wireless contraception in Tokyo, Japan, to help women activate self-care and self-empowerment. In 2002, Dr Wei was invited by the Dutch Health Promotion Board to develop a big data solution that will help the government correlate increasing teenage abortion trend with the country’s first introduction of digital youth education. Dr Wei has since received many international features for his work and became the youngest nominee for CNN’s People’s Choice award in 2003.
Over 15 years ago, Dr Wei founded Borderless Healthcare Group which started an investment in consumer-centric healthcare companies and has now become a global leader in the healthcare technology, media, telecommunication, service and content (TMTSC) space. Dr Wei continues to develop his vision from the digital and media space to now ‘connected’ online-to-offline health and wellness services via cloud computing with projects including technology-enabled wellness resorts, health and wellness metaverse and many other initiatives which are featured in numerous global international media.
Dr Wei is also recognized as a highly regarded keynote speaker in major international conferences globally such as Slush, BIOMED Israel, World Medical Tourism, etc and is also one of the most sought-after key opinion leaders in disruptive healthcare consumerism by global organizations and institutions such as United Nations, World Health Organization, Stanford University, Oxford University, Renmin University, etc.
Associate Professor Daniel Ting, Director of Singapore Health Service (SingHealth) AI Office
Associate Professor Daniel Ting is a senior consultant vitreo-retinal surgeon working in the Singapore National Eye Center (SNEC), an Associate Professor with Duke-NUS Medical School and an Adjunct Clinical Associate Professor and an Innovation Mentor at Stanford University. He is the Director of Singapore Health Service (SingHealth) AI Office, SNEC Chief Data and Digital Officer, and the Head of AI and Digital Innovation in Singapore Eye Research Institute (SERI). Dr Ting was also a US-ASEAN Fulbright Scholar of Johns Hopkins University Fulbright Scholar. He has current research focus not only on the clinical applied AI domains, but also technical aspects (e.g., machine learning, deep learning, large language models) and the AI safety (e.g., explainable AI, privacy preserving technologies) and ethics to ensure safe and responsible AI use in health.
To date, Associate Professor Daniel has published >250 publications on peer reviewed, book chapters, educational articles and conference abstracts, including those in high impact journals such as JAMA, NEJM, Lancet, Nature Medicine, Lancet Digital Health, Nature Biomedical Engineering, etc. In 2022 and 2023, he is listed as the World’s Top 100 Ophthalmologists Power list by the Ophthalmologists; and the World’s Top 2% Scientists by the Stanford University world ranking. In 2021, he was also ranked 1st globally in the deep learning domain over the past 10 years (2010 – 2021) by the ExpertScape.
Adjunct Associate Professor (Dr) Raymond Chua, Deputy Director of Medical Services (Health Regulation Group) at the Ministry of Health (Singapore)
Adjunct Associate Professor (Dr) Raymond Chua is a Registered Public Health Specialist and Fellow with the Academy of Medicine. As Deputy Director-General of Health, he oversees the regulation of healthcare services, premises, and health digitalization in Singapore, to safeguard public health, assure patient safety and ensure healthcare innovations.
He is concurrently designated as Assistant Commissioner for Cybersecurity in Healthcare, to assist in tracking and enhancing cybersecurity policies relating to Critical Information Infrastructures and Medical Devices in Singapore.
He also chairs the Public Service Division’s Regulatory Advisory Group to provide guidance and broad direction in using regulatory tools and capability development of regulators in the public service.
Professor Robert Morris, Head (Data, Science & Technology) and Chief Technology Strategist at the MOH Office for Healthcare Transformation (MOHT)
Professor Robert JT Morris is Chief Technology Strategist for the Ministry of Health Transformation (MOHT) Singapore and concurrently Professor, National University of Singapore Yong Loo Lin School of Medicine. He is also an Advisor to the National Research Foundation in the Prime Minister’s Office. His current focus is on application of computer and information sciences, including AI, to transform healthcare.
From 2011-2017, he led all IBM Research’s Global Laboratories, including Australia, Africa, China, India, Japan, Singapore and South America. IBM Research earned 6 Nobel prizes, laying the basis for the information revolution. In 2010 Fortune and Money Magazine declared Robert the “Smartest Scientist in Technology” in their print magazines and on the web.
During 2006-2011, Robert was VP Services Research, IBM TJ Watson Research Center, NY, helping start IBM’s healthcare and IoT businesses, and earlier VP Assets Innovation, IBM Global Services. From 1999-2004, he was the VP & Director of IBM Almaden Research Center, Silicon Valley, where relational database technology, the disk drive, etc., were invented. Responsible for creation of Services Science, research for IBM’s ThinkPad, and Storage Systems. Earlier he led advanced systems research at TJ Watson Center, including the Deep Blue chess machine, which defeated world champion Garry Kasparov in 1997. Originally from Australia, he began his career at Bell Labs working on early neural networks and the largest packet switch of the era. He has lived in and worked from Asia since 2011.
Robert was Chairman, Bay Area Science and Innovation Consortium (BASIC) 2001-2005, comprising heads of major research institutions in Silicon Valley. Published over 90 scientific articles, awarded 11 patents. Editor IEEE Trans. on Computers and on many boards. Received the Australian-American Fulbright and Gowrie Fellowships, PICMET Leadership in Tech. Mgmt. Award, Fellow IEEE, IBM Acad. of Technology, Government University Industry Research Roundtable (National Academies).
Mr David Lane, Emeritus Chairman at Thomson Adsett
As Emeritus Chairman of Thomson Adsett, David has practiced throughout Australia and Asia and directed over 4000 projects over the past 35 years. . He is also one of Australia’s best known architectural specialists in the Seniors Living industry, has a strong knowledge of international markets, and successfully secured work in all Asian markets.
David is a prolific and highly regarded public speaker and has authored numerous papers on residential design and ageing issues. He is currently collaborating with Borderless Healthcare Group to develop appropriate smart home design solutions for Real Estate 5.0, Modular Construction, and Ai Applications.
Ms Robyn Batten, Chair of the Board of Directors at Western Health (Australia); Former Executive Director of Blue Care
Robyn Batten AM has extensive experience as a CEO and Board Director and Chair in large and complex health and aged care organisations, across Australia. Robyn has been the CEO of Blue Care one of Australia's largest aged care providers and is currently board Chair of Western Health, Victoria's second largest health service. Organisational and service innovation in industries undergoing significant transformation have been a hallmark of Robyn's career. Robyn is also the founder and Executive Chair of a successful tech start up in the disability sector.
Robyn Batten has extensive experience in transforming services and organisations in large and complex health and aged care organisations as both a CEO and Board Chair
Mr Sean Lim, Director, Head of Unicorns Partnership for Asia at Microsoft
Sean has 27 years of regional experience in the InfoComm industry within Asia Pacific. He spent 11 years in telecommunications companies before transiting to Fortune 500 tech firms including Microsoft, Google, and Cisco, where he held various leadership roles. Sean now leads Microsoft's Unicorn business for Asia, where he forges strategic partnerships with billion-dollar start-ups to transform the markets. Sean serves as an independent board member for Versa-Fleet and Meet-Magic, has a dual MBA from INSEAD and Tsinghua University and is pursuing a DBA at Singapore Management University. Sean loves endurance sports and is an active Ironman and ultra-marathon athlete.
Mr Andy Ta Wee An, Director of Data Analytics & AI and Chief Data Officer at Synapxe
Andy is responsible for the visioning, planning and implementation of system-wide and institution-level data, analytical & AI capabilities/ programmes across the care continuum for effective enablement of analytics and data science across public health organisations in alignment to Ministry of Health’s Healthcare Masterplan.
Andy’s efforts include building a strong AI & data science community in healthcare, encouraging collaborations among public health institutions to implement innovative or transformative approaches to healthcare services, patient care delivery and population health through use of big data and advanced analytics.
Andy has published six papers, including “Development and Implementation of Nationwide Predictive Model for Admission Prevention” paper publication by IEEE Engineering in Medicine and Biology Society (EMBS) in March 2018
Dr Georgio Mosis, Head of Borderless.ai; Holds PHD in Healthcare Big Data
Dr. Georgio Mosis —a seasoned leader with global experience in the digital transformation realm. He is the co-founder of SynaGenic, a company specializing in creating hybrid intelligent workforces that combine human and artificial intelligence.
He has more than 20 years of experience in corporate innovation, with a global perspective on digital transformation for companies like Philips, Reinsurance Group America, and AIA Insurance. A fervent advocate for fostering innovation-centric cultures, Georgio strategically drives business growth within complex ecosystems, showcasing the potential of technology under visionary leadership.
He is also a board member, strategic partner, and advisor of various companies in the fields of healthcare, insurance, education, and technology.
Georgio earned his PhD in Clinical Epidemiology from Erasmus University, an executive MBA from Nyenrode Business University, and a master's degree in Medical Informatics from the University of Amsterdam.
Anastasia Miros, Director for Health & Life Sciences (Asia Pacific) at KPMG
As the Director leading KPMG’s Healthcare and Life Sciences practice in Asia Pacific, Anastasia is passionate about partnering for outcomes, innovating for impact and leveraging digital, data and AI to deliver value for people across the healthcare ecosystem. With over 20 years global and regional Life Sciences (MedTech, Pharma and Digital Health) and Healthcare (Public and Private) industry experience delivering large-scale transformation initiatives across a variety of first-line and second-line roles, Anastasia couples her strategic and sector expertise with strong data science and engineering foundations and qualifications to help drive, create and translate value across the healthcare ecosystem; for patients, providers, businesses and systems. Anastasia’s key focus areas are (1) digital, data and AI strategies (2) commercial strategy and innovative GTM and (3) innovation and emerging technology strategies.
Borderless Healthcare Group. All rights reserved. ©️ 2024.